"El Sanatorio Modelo Quilmes, con 47 años de trayectoria, es una de las instituciones médicas más prestigiosas del país. Sus valores y principios éticos cimentaron las capacidades centrales de la empresa y se manifiestan en la jerarquía y profesionalidad de los servicios médicos que brinda a su comunidad. Acreditado en CENAS (Centro Especializado para la Normalización y Acreditación en Salud) por la calidad de la atención médica. Institución médica afiliada UBA (Facultad de Medicina de la Universidad de Buenos Aires)."

During the past decade, Sanatorio Modelo Quilmes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Modelo Quilmes" #1 collaborator was "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Sociedad Interamericana de Cardiología (SIAC)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio Modelo Quilmes" are "Heart Failure" (2 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Myocardial Infarction" (1 trials) and "Thrombolysis in Myocardial Infarction Flow" (1 trials). Many other conditions were trialed in "Sanatorio Modelo Quilmes" in a lesser frequency.

Most popular intervention types in "Sanatorio Modelo Quilmes" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clopidogrel" (1 trials), "Empagliflozin" (1 trials), "Finerenone (BAY94-8862)" (1 trials) and "Ticagrelor 180 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Modelo Quilmes" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sanatorio Modelo Quilmes". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sanatorio Modelo Quilmes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Modelo Quilmes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".